1. Development and Validation of a Three-Gene-Based Prognostic Model for Predicting the Overall Survival of Head and Neck Squamous Cell Carcinoma Through Bioinformatics Analysis
   Yiyuan Han et al, 2022, Frontiers in Genetics CrossRef
2. The Hypoxia-Related Gene COL5A1 Is a Prognostic and Immunological Biomarker for Multiple Human Tumors
   Hua Zhu et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
3. Virtual Screening and Network Pharmacology-Based Study to Explore the Pharmacological Mechanism of Clerodendrum Species for Anticancer Treatment
   Barbi Gogoi et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
4. COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma
   Hongbo Wang et al, 2021, Experimental and Therapeutic Medicine CrossRef
5. Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma
   Houxiang Jiang et al, 2023, Discover Oncology CrossRef
6. Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma
   Yongqiang Zhang et al, 2021, World Journal of Surgical Oncology CrossRef
7. ABERRANT EXPRESSION OF COL14A1, CELRS3, and CTHRC1 IN BREAST CANCER СELLS
   Шрешта Малвія et al, 2023, Experimental Oncology CrossRef
8. Mining the Biomarkers and Associated-Drugs for Esophageal Squamous Cell Carcinoma by Bioinformatic Methods
   Xiuying Kuang et al, 2022, The Tohoku Journal of Experimental Medicine CrossRef
9. EFNA1in gastrointestinal cancer: Expression, regulation and clinical significance
   Ling-Yu Chu et al, 2022, World Journal of Gastrointestinal Oncology CrossRef